Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227069 · ClinicalTrials.gov registry record · Phase 1
Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers
A Phase 1 study, sponsored by Maruho North America.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT02227069 is a Phase 1 study that has completed, run by Maruho North America. The registered enrollment target is 30 participants.
The verdict
NCT02227069, a Phase 1 study, has completed, sponsored by Maruho North America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single center, randomized, controlled, within-subject comparison, multiple dose study to determine the irritation potential of M518101 on normal skin under occlusive patch condition. The study drug will be applied for 21 days under occlusive patch condition. The irritation potential of M518101 will be compared with positive, negative control and M518101 vehicle. The study duration is 21days and there will be at least 23 visits to study center including screening visit.
Interventions
- OTHER saline
- DRUG M518101
- DRUG M518101 Vehicle
- OTHER sodium lauryl sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02227069
The ClinicalTrials.gov registry entry for NCT02227069 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maruho North America, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which saline is the first listed.
NCT02227069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02227069 about?
NCT02227069 is a clinical study titled "Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers". This is a single center, randomized, controlled, within-subject comparison, multiple dose study to determine the irritation potential of M518101 on normal skin under occlusive patch condition. The study drug will be applied for 21 days under occlusive patch condition. The irritation potential of M5...
What is the current status of trial NCT02227069?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2014-09. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02227069?
The interventions under investigation include: saline (OTHER), M518101 (DRUG), M518101 Vehicle (DRUG), sodium lauryl sulfate (OTHER).
Who is sponsoring clinical trial NCT02227069?
This trial is sponsored by Maruho North America, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.